Evidence map›Paper›PMID 25868786›Full record

ArticleCurrent treatment options in gastroenterology2015

Endoscopic bariatric procedures.

Jacques Deviere

Abstract read
PubMed Publisher
In one paragraph

Article in Current treatment options in gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jacques DeviereDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Erasme University Hospital, Université Libre de Bruxelles, Route de Lennik 808, B-1070, Brussels, Belgium, Jacques.Deviere@erasme.ulb.ac.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

opinion statementObesity is a pandemy which affects 600 million adults worldwide. Surgery is the only therapy which has been shown effective on the long term. Transoral surgery (or endotherapy) is particularly attractive in this group of patients and has the potential for offering a less invasive alternative. If the only treatment currently available in routine is balloon implantation, which is effective at short term but unfortunately associated with weight regain after removal in the majority of the cases, other techniques currently under development or clinical investigations might fine their place in future treatment armamentarium. They include restrictive procedures, involving plicature formation or tissue apposition in order to reduce the volume of the stomach, decrease its compliance, and favor an early satiety. Other techniques focus on malabsorption, either by bypassing the contact of food with the jejunum (a feature which also improves type 2 diabetes) or by emptying the stomach after food intake. Several techniques also allow performing gastrojejunal anastomoses. These could be particularly useful in designing hybrid procedures combining laparoscopic and transoral approach resulting in less invasive surgical procedures. Even if, currently, none of these techniques can be recommended outside clinical protocols, it becomes more and more obvious that some of them will find their place in the near future.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.